ArticleJournal of clinical medicine2022

Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.

Diletta Valentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.